By David Woods ([email protected]) The pharmaceutical industry is too often blamed for the stratospheric costs of healthcare — particularly in the United States. Yet, according to a series of surveys…
Details
By Mary Gabb ([email protected]) With all of the recent news about job cuts or outsourcing in the pharmaceutical industry, health economists maybe worried about their own employment, as the downturn…
Details
By David Woods ([email protected]) With this the 26th issue of HOC, we are well overdue in featuring our energetic, globetrotting CEO of Rx Communications, Ruth Whittington. I can say this…
Details
By Julie Stauffer (julie.stauffer.rxcomms.com) Sustaining staff morale is about much more than delivering a wage slip at the end of the month. If the past few years of restructurings, closures,…
Details
By Mary Gabb ([email protected]) Obnoxious, annoying, Big Pharma strikes again – these are just some of the sentiments heard when encountering a direct-to-consumer (DTC) advertisement, the myriad commercials on radio…
Details
By David Woods ([email protected]) There has been much written lately about the perceived failings of the FDA. The Wall Street Journal claims that “the place is a mess,” and a…
Details
By Mary Gabb ([email protected]) As health economics plays a more prominent role in medical research and public policy, participation in panel discussions – either in front of a live audience…
Details
While economics is the main ingredient in most healthcare decisions today, health economics still has many pharmacologists, clinicians, physicians and marketing personnel left confused and appalled that quality of life…
Details
By Robert Hand ([email protected]) For those interested in entering or advancing in the field of health economics and outcomes research, and for those looking for newly-minted researchers to employ, it…
Details
By David Woods ([email protected]) Dr. Patti Peeples: what a perfect name for the subject of HOC people! She tells me that the origin of the name is from Peebles, in…
Details
